Summary clinical studies
All clinical studies
| NCT ID | Research | Preclin | Phase 1 | Phase 2 | Phase 3 |
|---|
| Colorectal Cancer | ||
| 03750786 | AGENT ISO-CC-007, Phase III. Pivotal study with 440 patients undergoing first line treatment for metastatic colorectal cancer (mCRC). Clinical Trial >> | |
| 01681472 | ISO-CC-002, a Phase I/II Pharmacockinetics and pharmacodynamics clinical investigation of arfolitixorin (Modufolin®) in Plasma, Tumor and Adjacent Mucosa in Patients with Colon Cancer. Clinical Trial >> | |
| 01397305 | ISO-MC-091, Phase I/II Study where Pemetrexed is co-administered with arfolitixorin (Modufolin®) to newly diagnosed, non-cytostatically-treated patients with resectable Rectal Cancer. Clinical Trial >> | |
| 02244632 | ISO-CC-005, Phase I/II arfolitixorin (Modufolin®) in Combination with 5-Fluorouracil Alone or with Irinotecamn or Oxaliplatin ± bevacizumab in patients with colorectal cancer. | |
| Osteosarcoma | ||
| 02383901 | ISO-MTX-OB1, A Retrospective Non-intervention Study tto investigate how rescue treatment with folates in patients with osteosarcoma works in clinical context. Clinical Trial >> | |
| 01987102 | ISO-MTX-003, Phase I/II study intended to identify the arfolitixorin (Modufolin®) dose to be used in continued clinical development for in the osteosarcoma indication. Clinical Trial >> |